NOVAK is a visionary projection of the New World that holds
relevance in the realms of biopsycho-software engineering,
revolutionising the way we perceive and engage with our current climate.
Mission Philosophy
12 APRIL 2099
Neuroscience Outcomes Research
Neural Correlates of Pleasure Perception
3 JUNE 2099
Reward Pathways and Dopaminergic Systems Research
Motivation, Reinforcement Learning,
and Decision-Making Processes
26 AUGUST 2099
Neurobiology of Addiction & Hedonic Dysregulation Research
Abuse or Compulsive Behavior Research
8 NOVEMBER 2099
Neurotechnology for Pleasure Modulation Research
Deep Brain Stimulation (DBS), Transcranial Magnetic
Stimulation (TMS), and Optogenetics
Founded by a group of neuroscientists and group of entrepreneurs passionate about resolving the overconsumption crisis and depleting natural resources.
Y 2053
Novak establishes its first research laboratory dedicated to studying human
desire with the aid of Artificial Intelligence
Novak pioneers the use of artificial physiological techniques to map neural circuits involved in pleasure processing
Y2065
Our Company secured the first major research grant, allowing for expansion of its research facilities and patent of our invention of
Dr. Novak, software for analysing neuroimaging data related to desire
Y 2072
Novak publishes groundbreaking research demonstrating the role of Artificial Intelligence in 99.9% accuracy in diagnosis
Novak receives regulatory approval and begins its first human patient trials for its first product, CONTENTA.
Novak collaborates with the central government to research on other ways to create artificial neuro-satisfaction.
Our company launches its first flagship product, CONTENTA, to the public.
Y 2092
Novak expands its research focus to include neurotechnology for modulating pleasure circuits in the brain, leading to the development of experimental therapies.
Y 2095
Our company partners with academic institutions to launch a large-scale longitudinal study investigating the neurobiological correlates of long-term happiness.
Our company partners with academic institutions to launch a large-scale longitudinal study investigating the neurobiological correlates of long-term happiness.
Our company launches a global initiative to promote ethical and responsible use of neurotechnologies for pleasure enhancement, addressing societal concerns and regulatory challenges.